COMMUNIQUÉS West-GlobeNewswire

Precipio Announces Third Quarter 2018 Corporate Update Call for Shareholders
15/11/2018
Conference Call to Be Held Monday, November 19, 2018 at 5:00 PM ET NEW HAVEN, Conn., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) will be hosting its third [...]
Helius Medical Technologies, Inc. Announces Pricing of Public Offering of Class A Common Stock
15/11/2018
NEWTOWN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,121,212 shares of [...]
VPR Brands, LP Announces Third Quarter 2018 Results
15/11/2018
FORT LAUDERDALE, FL, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- VPR Brands, LP (OTC PINK: VPRB) (“VPR Brands”), a market leader in innovation specializing in accessories and vaporizers for essential oils, [...]
Cannabix Technologies Engages MistyWest - Provides Development Update on Marijuana Breathalyzer
15/11/2018
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE [...]
Novo Nordisk A/S - Share repurchase programme
15/11/2018
Bagsværd, Denmark, 15 November 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
TRACON Pharmaceuticals Presents New Circulating Tumor Cell Data from Ongoing Pivotal Phase 3 TAPPAS Trial of TRC105 and Votrient® in Patients with Angiosarcoma
15/11/2018
Changes in Endoglin Expressing Circulating Tumor Cells (CTC) Detected in Phase 3 TAPPAS Trial Changes in CTC count may be useful as a prognostic biomarker and baseline CTC may be useful as a predictive biomarker SAN [...]
Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 2018
15/11/2018
Minerva management to provide update on Phase 3 clinical trial with roluperidone and single-dose escalation study findings Additional topics to include review of recent BDNF data with roluperidone and KOL discussion of [...]
Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting
15/11/2018
Company Reviews Mechanism of Action, Preclinical Outcomes and Phase 1 Safety Results of VX15 (pepinemab) as Single Agent and In Combination Therapy Against Multiple Cancers ROCHESTER, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE [...]
Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference
15/11/2018
SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber, Ph.D., [...]
International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018
15/11/2018
Increases in Revenues and Profit Margins Net Income Realized for the Quarter CARLSBAD, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO [...]
Align Technology Ongoing Support of Orthodontic and Dental Research
15/11/2018
2019 Grant Application Process Now Open for up to $300,000 in Funding SAN JOSE, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2019 Research Award [...]
Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018
15/11/2018
DCCR treatment resulted in statistically significant decreases in body fat in subjects with Prader-Willi Syndrome REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a [...]
Inovio Prepares for Growth & Commercialization With Leadership Appointments
15/11/2018
Prominent immunologist joins Scientific Advisory Board R&D leader appointed Chief Scientific Officer Industry veteran appointed Vice President, Commercial PLYMOUTH MEETING, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- [...]
Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018
15/11/2018
Company continues on track to initiate combined Phase 3 clinical trial in Alström Syndrome and Bardet-Biedl Syndrome before end of 2018 BOSTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM [...]
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results
15/11/2018
REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Genocea To Host a Key Opinion Leader Event November 26th on Latest Advances in Personalized Cancer Immunotherapies
15/11/2018
Event to be webcast live at 12 pm ET CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, announced [...]
SPR Therapeutics Announces First Use of SPRINT endura Peripheral Nerve Stimulation System to treat Complex Regional Pain Syndrome
15/11/2018
SPRINT System is the least invasive PNS device for CRPS CLEVELAND, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Marc Huntoon [...]
Maverick Technology Solutions’ ROSINBOMB™ ROCKET is Now Patent Pending
15/11/2018
Company Files its Second Patent Application with the US Patent and Trademark Office for its innovative consumer extraction press. RENO, Nev., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC: MVRK ) [...]
Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference
15/11/2018
MALVERN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]

Pages